Venous Thromboembolism
"Venous Thromboembolism" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Obstruction of a vein or VEINS (embolism) by a blood clot (THROMBUS) in the blood stream.
Descriptor ID |
D054556
|
MeSH Number(s) |
C14.907.355.590.700
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Venous Thromboembolism".
Below are MeSH descriptors whose meaning is more specific than "Venous Thromboembolism".
This graph shows the total number of publications written about "Venous Thromboembolism" by people in this website by year, and whether "Venous Thromboembolism" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
Year | Major Topic | Minor Topic | Total |
---|
2008 | 1 | 1 | 2 | 2009 | 3 | 0 | 3 | 2010 | 8 | 3 | 11 | 2011 | 5 | 2 | 7 | 2012 | 4 | 2 | 6 | 2013 | 5 | 1 | 6 | 2014 | 8 | 2 | 10 | 2015 | 9 | 1 | 10 | 2016 | 6 | 1 | 7 | 2017 | 10 | 3 | 13 | 2018 | 8 | 1 | 9 | 2019 | 10 | 0 | 10 | 2020 | 20 | 1 | 21 | 2021 | 14 | 2 | 16 | 2022 | 8 | 0 | 8 |
To return to the timeline, click here.
Below are the most recent publications written about "Venous Thromboembolism" by people in Profiles.
-
Bellfi LT, Zimmerman SA, Boudreau R, Mosier W, Smith A, Rueb N, Hunt JP, Stuke L, Greiffenstein P, Schoen J, Marr A. Impact of Increased Enoxaparin Dosing on Anti-Xa Levels for Venous Thromboembolism Prophylaxis in Trauma Patients. Am Surg. 2022 Sep; 88(9):2158-2162.
-
Novak AR, Shakowski C, Trujillo TC, Wright GC, Mueller SW, Kiser TH. Evaluation of safety and efficacy outcomes of direct oral anticoagulants versus warfarin in normal and extreme body weights for the treatment of atrial fibrillation or venous thromboembolism. J Thromb Thrombolysis. 2022 Aug; 54(2):276-286.
-
Hess CN, Szarek M, Anand SS, Bauersachs RM, Patel MR, Debus ES, Nehler MR, Capell WH, Beckman JA, Piazza G, Henkin S, Bura-Rivière A, Lawall H, Roztocil K, Hsia J, Muehlhofer E, Berkowitz SD, Haskell LP, Bonaca MP. Rivaroxaban and Risk of Venous Thromboembolism in Patients With Symptomatic Peripheral Artery Disease After Lower Extremity Revascularization. JAMA Netw Open. 2022 06 01; 5(6):e2215580.
-
Bradsell HL, Lencioni A, Frank RM. Incidence and Prevention of Thromboembolic Complications for Sports and Arthroscopic-related Surgery: Evidence-based Recommendations. Sports Med Arthrosc Rev. 2022 Mar 01; 30(1):24-28.
-
Kleiboer B, Layer MA, Cafuir LA, Cuker A, Escobar M, Eyster ME, Kraut E, Leavitt AD, Lentz SR, Quon D, Ragni MV, Thornhill D, Wang M, Key NS, Buckner TW. Postoperative bleeding complications in patients with hemophilia undergoing major orthopedic surgery: A prospective multicenter observational study. J Thromb Haemost. 2022 04; 20(4):857-865.
-
Thoppil JJ, Courtney DM, McDonald S, Kabrhel C, Nordenholz KE, Camargo CA, Kline JA. SARS-CoV-2 Positivity in Ambulatory Symptomatic Patients Is Not Associated With Increased Venous or Arterial Thrombotic Events in the Subsequent 30 Days. J Emerg Med. 2022 06; 62(6):716-724.
-
Courtney LA, Trujillo TC, Saseen JJ, Wright G, Palkimas S. Evaluation of the Clinical Impact of Thromboprophylaxis in Patients With COVID-19 Following Hospital Discharge. Ann Pharmacother. 2022 09; 56(9):981-987.
-
Goldenberg NA, Kittelson JM, Abshire TC, Bonaca M, Casella JF, Dale RA, Halperin JL, Hamblin F, Kessler CM, Manco-Johnson MJ, Sidonio RF, Spyropoulos AC, Steg PG, Turpie AGG, Schulman S. Effect of Anticoagulant Therapy for 6 Weeks vs 3 Months on Recurrence and Bleeding Events in Patients Younger Than 21 Years of Age With Provoked Venous Thromboembolism: The Kids-DOTT Randomized Clinical Trial. JAMA. 2022 01 11; 327(2):129-137.
-
Carney BJ, Wang TF, Ren S, George G, Al Homssi A, Gaddh M, Connolly GC, Shah VI, Bogue T, Bartosic A, Neuberg D, Baumann Kreuziger L, Zwicker JI. Anticoagulation in cancer-associated thromboembolism with thrombocytopenia: a prospective, multicenter cohort study. Blood Adv. 2021 12 28; 5(24):5546-5553.
-
Spyropoulos AC, Goldin M, Giannis D, Diab W, Wang J, Khanijo S, Mignatti A, Gianos E, Cohen M, Sharifova G, Lund JM, Tafur A, Lewis PA, Cohoon KP, Rahman H, Sison CP, Lesser ML, Ochani K, Agrawal N, Hsia J, Anderson VE, Bonaca M, Halperin JL, Weitz JI. Efficacy and Safety of Therapeutic-Dose Heparin vs Standard Prophylactic or Intermediate-Dose Heparins for Thromboprophylaxis in High-risk Hospitalized Patients With COVID-19: The HEP-COVID Randomized Clinical Trial. JAMA Intern Med. 2021 12 01; 181(12):1612-1620.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|